Key Segmentation:
By Product
-
Urethral and Vaginal Slings
-
Artificial Urinary Sphincters
-
Electrical and Neuromodulation Devices
-
Urinary Catheters
-
Pessary
-
Other Devices
By Device Category
-
Internal Systems
-
External Solutions
By Incontinence Type
-
Stress Incontinence
-
Urge Incontinence
-
Overflow Incontinence
-
Functional Incontinence
-
Mixed Incontinence
By End User
-
Hospitals
-
Home-Care and Long-Term Care Settings
-
Ambulatory Surgical Centers
-
Specialty Clinics
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Boston Scientific Corporation, Medtronic plc, Coloplast A/S, Hollister Incorporated, and B. Braun Melsungen AG, among other medical device manufacturers.
Continued expansion of implantable tibial neuromodulation and continued growth of home-based and long-term care management represent the primary opportunities.
Growth is primarily driven by a rapidly ageing global population, combined with continued innovation toward minimally invasive treatment options.
By Product, Urethral and Vaginal Slings dominated the market with a 34.68% share in 2025, reflecting decades of surgical familiarity and mature supply chains.
North America dominated the market with a 37.85% share in 2025, supported by broad insurance coverage and a large, ageing population.